Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.35M Buy
10,286
+5,692
+124% +$1.39M 0.07% 169
2022
Q2
$1.03M Buy
4,594
+1,806
+65% +$416K 0.03% 255
2022
Q1
$724K Buy
2,788
+478
+21% +$120K 0.02% 305
2021
Q4
$675K Buy
2,310
+504
+28% +$139K 0.02% 295
2021
Q3
$487K Sell
1,806
-953
-35% -$259K 0.01% 321
2021
Q2
$657K Buy
2,759
+528
+24% +$117K 0.02% 226
2021
Q1
$445K Buy
2,231
+229
+11% +$46.5K 0.02% 213
2020
Q4
$394K Buy
2,002
+465
+30% +$93.2K 0.03% 183
2020
Q3
$294K Buy
+1,537
New +$273K 0.03% 219

Other funds holding DHR

55I LLC's DHR Position: Q3 2022 in Review

55I LLC increased its Danaher (DHR) stake by 124% in Q3 2022, buying an estimated $1.39M and bringing the position to 10,286 shares worth $2.35M. The position accounts for 0.07% of the portfolio, ranked #169.

55I LLC first reported a position in DHR in Q3 2020 and has held it in 9 quarters since. 2,028 funds tracked by Wall St. Rank hold DHR as of Q3 2022.

  • 55I LLC held 10,286 shares of Danaher worth $2.35M as of Q3 2022.
  • 55I LLC bought 5,692 Danaher shares in Q3 2022, an estimated $1.39M.
  • Danaher made up 0.07% of 55I LLC's portfolio in Q3 2022, its #169 holding.
  • 55I LLC first reported a position in Danaher in Q3 2020 and has held it in 9 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Danaher as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.